Clinical Trials and Post-Market Side Effects
Oct 21, 2022•34 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Drs. Sarah Read, M. Ali Khan, and Ajay Kuriyan join a group discussion on incorporating newly approved medications into practice, focusing on real-world examples of Vuity (pilocarpine drops), brolucizumab, and drugs for dry AMD in trial.
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
For the best experience, listen in Metacast app for iOS or Android